Hvivo plc acts as a holding company with investments in its wholly owned subsidiaries, hVIVO Services Limited and hVIVO Inc. The primary business activity of hVIVO Services Limited involves conducting human challenge studies and providing laboratory services for clinical trials on behalf of commercial clients. The company serves the biopharmaceutical sector, focusing on accelerating the development of new therapies. It operates primarily in the United Kingdom and has minority investments in associates, including Prep Biopharm Limited and Imutex Limited.